Notice
본문 바로가기
메인메뉴
Company
About Qurient
History
Management
Contact Us
Business Philosophy
Pipeline
Pipeline
Adrixetinib (Q702)
Q901
Q301
Telacebec (Q203)
5-Lipoxygenase Inhibitor
Clinical Trials
Clinical Trials
IR / PR
Notice
Press Release
Qurient in the news
Financial
Disclosure
Blog
WEBTOON
WEBTOON
Company
Pipeline
Clinical Trials
IR / PR
WEBTOON
Notice
Press Release
Qurient in the news
Financial
Disclosure
Blog
Notice
주식액면분할에 따른 구주권 제출 공고
페이지 정보
Author
QURIENT
Date
2015-09-01 11:15
Views
13,409
본문
Prev
Next
List
information for download file
* Name
Company
Phone
* Business e-mail
Comment
Request Download
팝업 닫기
Notice